Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Drugs in Context|March 17, 2023
HR+/HER2- de novo metastatic breast cancer: a true peculiar entity?Rosalba Torrisi, Flavia Jacobs, Chiara Miggiano, et al.Cancers|January 8, 2023
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast CancerFlavia Jacobs, Mariangela Gaudio, Chiara Benvenuti, et al.Cancers|June 10, 2023
Hope and Hype around Immunotherapy in Triple-Negative Breast CancerFlavia Jacobs, Elisa Agostinetto, Chiara Miggiano, et al.Journal of Clinical Medicine|March 11, 2023
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with AbemaciclibFlavia Jacobs, Elisa Agostinetto, Alessandra Solferino, et al.Biomedicines|May 16, 2023
Clinical Review on the Management of Breast Cancer Visceral CrisisChiara Benvenuti, Mariangela Gaudio, Flavia Jacobs, et al.Cancers|August 29, 2024
Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship CareMarco Balordi, Paola Tiberio, Matteo Castaldo, et al.Cancers|April 14, 2025
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic ResponsesJacopo Canzian, Fabio Conforti, Flavia Jacobs, et al.Cancers|March 11, 2023
Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to PaveChiara Benvenuti, Paola Tiberio, Mariangela Gaudio, et al.Frontiers in Pharmacology|September 26, 2022
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compoundsRita De Sanctis, Flavia Jacobs, Chiara Benvenuti, et al.Cancers|November 11, 2022
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast CancerElisa Agostinetto, Flavia Jacobs, Véronique Debien, et al.Pageof 5